Authors: BIEWENGA GP HAENEN GRMM GROEN BH BIEWENGA JE VANGRONDELLE R BAST A

Citation: Gp. Biewenga et al., COMBINED NONENZYMATIC AND ENZYMATIC REDUCTION FAVORS BIOACTIVATION OFRACEMIC LIPOIC ACID - AN ADVANTAGE OF A RACEMIC DRUG, Chirality, 9(4), 1997, pp. 362-366

Authors: BIEWENGA JE DESTREE OHJ SCHRAMA LH

Citation: Je. Biewenga et al., PLASMID-MEDIATED GENE-TRANSFER IN NEURONS USING THE BIOLISTICS TECHNIQUE, Journal of neuroscience methods, 71(1), 1997, pp. 67-75

Authors: SCHOTMAN P BIEWENGA JE SCHRAMA LH VANROZEN AJ GISPEN WH AARTS LHJ

Citation: P. Schotman et al., ACTIVATION OF RHO BY B-50 (GAP-43) IN RAT-1 FIBROBLASTS, Journal of neurochemistry, 69, 1997, pp. 23-23

Authors: BIEWENGA JE SCHRAMA LH GISPEN WH

Citation: Je. Biewenga et al., PRESYNAPTIC PHOSPHOPROTEIN B-50 GAP-43 IN NEURONAL AND SYNAPTIC PLASTICITY/, Acta Biochimica Polonica, 43(2), 1996, pp. 327-338

Authors: MOLENAAR PC BIEWENGA JE VANKEMPEN GTH DEPRIESTER JA

Citation: Pc. Molenaar et al., EFFECT OF EPHEDRINE ON MUSCLE WEAKNESS IN A MODEL OF MYASTHENIA-GRAVIS IN RATS, Neuropharmacology, 32(4), 1993, pp. 373-376